{"title":"中枢神经系统药物研究的动物模型。","authors":"G J Parry","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>An animal model which allowed repetitive sampling of CSF is described. It had a wide potential application and was used to study the passage of clonazepam into the central nervous system. A highly sensitive clonazepam assay is described which allow measurement of CSF and free serum concentrations as low as 0.5 ng/ml. Clonazepam passed rapidly into the central nervous system and its CSF concentration closely approximated to the concentration of unbound clonazepam in serum. Protein binding of clonzaepam in the sheep was 90-95%.</p>","PeriodicalId":76351,"journal":{"name":"Proceedings of the Australian Association of Neurologists","volume":"13 ","pages":"83-8"},"PeriodicalIF":0.0000,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An animal model for the study of drugs in the central nervous system.\",\"authors\":\"G J Parry\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>An animal model which allowed repetitive sampling of CSF is described. It had a wide potential application and was used to study the passage of clonazepam into the central nervous system. A highly sensitive clonazepam assay is described which allow measurement of CSF and free serum concentrations as low as 0.5 ng/ml. Clonazepam passed rapidly into the central nervous system and its CSF concentration closely approximated to the concentration of unbound clonazepam in serum. Protein binding of clonzaepam in the sheep was 90-95%.</p>\",\"PeriodicalId\":76351,\"journal\":{\"name\":\"Proceedings of the Australian Association of Neurologists\",\"volume\":\"13 \",\"pages\":\"83-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1976-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the Australian Association of Neurologists\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the Australian Association of Neurologists","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
An animal model for the study of drugs in the central nervous system.
An animal model which allowed repetitive sampling of CSF is described. It had a wide potential application and was used to study the passage of clonazepam into the central nervous system. A highly sensitive clonazepam assay is described which allow measurement of CSF and free serum concentrations as low as 0.5 ng/ml. Clonazepam passed rapidly into the central nervous system and its CSF concentration closely approximated to the concentration of unbound clonazepam in serum. Protein binding of clonzaepam in the sheep was 90-95%.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
